Vivos Therapeutics, Inc. Announces Opening of New Testing & Treatment Facility

What Happened

• Vivos Therapeutics, Inc. announced on August 20, 2026 (via press release) the opening of a new testing and treatment facility. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K filed on August 21, 2026 under Item 7.01 (Regulation FD Disclosure).

Key Details

• Press release date: August 20, 2026.
• 8‑K filing date: August 21, 2026.
• Disclosure type: Item 7.01 — Regulation FD Disclosure; press release furnished as Exhibit 99.1.
• The Form 8‑K did not include financial statements or quantitative financial information related to the facility opening.

Why It Matters

• The company has publicly disclosed an operational expansion (a new testing and treatment facility), which is a business development investors may track. The 8‑K provides the official public notice but contains no financial details or guidance; investors seeking impact on revenue, patient volume, or costs should look for future company reports or releases for those metrics.